Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1981
11/17/1981US4301152 Immunologic adjuvant
11/17/1981US4301148 Anticocoidial drug
11/17/1981US4301064 Ubiquitary tissue protein PP8
11/17/1981CA1112570A1 Preparations for vaginal administration
11/17/1981CA1112566A1 High molecular weight meningococcal group c vaccine and method for preparation thereof
11/12/1981WO1981003244A1 Means and method to provide lasing
11/12/1981WO1981003124A1 Polypeptide fraction from mussel for medical use
11/11/1981EP0039637A1 Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
11/10/1981CA1112168A1 Freeze-drying process for the preparation of meningococcus vaccine without degradation of potency
11/10/1981CA1112167A1 Vaccines from a new strain of rabies virus
11/10/1981CA1112166A1 Method of preparing and intravenously administrable immune globulin preparation containing antibodies and preparations produced according to this method
11/03/1981US4298597 Prevention of diarrhea in newborn calves by administering vaccine to cow before parturition
11/03/1981US4298596 Trypanosoma cruzi glycoprotein vaccine for inducing immunity to Chagas' disease
11/03/1981CA1111762A1 Fluorescent rare earth chelate in polymeric latex particles
10/1981
10/29/1981WO1981002978A1 Modified living canine parvovirus vaccine
10/28/1981EP0038765A1 Vaccine against viral hepatitis B, method and transformed eucaryotic cells for the preparation of this vaccine
10/28/1981EP0038750A1 Immunologically active dipeptidyl 4-0-, 6-0-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
10/28/1981EP0038667A1 IgM derivatives and process for the preparation thereof
10/28/1981EP0038642A1 A monoclonal antibody against hepatitis B and its production, a hybridoma producing the monoclonal antibody and compositions containing it, the propagation of the hybridoma and the monoclonal antibody for use as an antiviral agent against hepatitus B and in isolating hepatitus b surface antigen from a sample
10/27/1981US4297343 Contraceptive agent
10/27/1981US4297272 Water soluble, by treatment with a base or a hypobromite
10/27/1981CA1111415A1 Chromatographie separation and purification of proteins
10/21/1981EP0038265A1 Group B streptococcal capsular polysaccharides
10/21/1981EP0038154A1 Allergens modified with polysarcosines
10/21/1981EP0038153A2 Modified allergens
10/21/1981EP0037931A2 Process for preparing an immunogenic membranous protein aggregate of influenza, parainfluenza and rhabdo viruses
10/20/1981US4296097 Suppression of reaginic antibodies to drugs employing polyvinyl alcohol as carrier therefor
10/20/1981CA1110968A1 Antigenic complex from n. gonorrhoeae
10/14/1981EP0037522A2 Derivatives of the heat stable enterotoxin of Escherichia coli, and their preparation
10/13/1981CA1110617A1 Glycoprotein and process for isolating it
10/07/1981EP0037330A2 Method of growing hepatitis B surface antigen
10/07/1981EP0036995A1 Veterinary vaccines for pasteurellosis
10/07/1981EP0036862A1 Snake venom neurotoxin prophylaxis and therapy for poisonous organophosphates
10/06/1981US4293653 Method for propagating feline infectious peritonitis virus
10/06/1981US4293545 Immunology
10/06/1981CA1110187A1 Protein immobilizer
10/01/1981WO1981002674A1 Virus-inhibiting substance and process for preparing the same
09/1981
09/30/1981EP0036776A2 A method of creating an expression plasmid
09/29/1981US4292308 Treatment of animals exposed to or subject to exposure to organophosphate animal poisonous nerve agents
09/29/1981US4292307 Antigens free of cells and protein; immunology
09/23/1981EP0036372A1 Ganglioside derivatives, their preparation and their application
09/23/1981EP0036277A2 Covalently bonded liposome-protein-compositions and method of producing them
09/22/1981US4291020 Inactivation of non-A, non-B hepatitis agent
09/22/1981US4291019 Extracting viral coat protein from infected cells
09/22/1981US4290944 Antigenic peptide compound
09/22/1981CA1109393A1 Vaccine and its preparation
09/17/1981WO1981002522A1 Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
09/17/1981WO1981002520A1 Compositions for therapeutic or diagnostic use in connection with bacterial infections,and their use
09/16/1981EP0035616A1 Production of immunoglobulin having a high monomer content
09/09/1981EP0035484A2 Composition for therapeutic or diagnostic use
09/09/1981EP0035429A1 Vaccinal complex containing a specific antigen and vaccine containing it
09/09/1981EP0035265A2 Agent for tumor localization and therapy with labeled antibodies and antibody fragments
09/09/1981EP0035204A2 Pasteurized therapeutically active protein compositions
09/08/1981US4288557 From extracted, substantially rna- and dna-free cell surface
09/08/1981CA1108534A1 LEUCINE-RICH 3,1-S-.alpha..SUB.2-GLYCOPROTEIN, PROCESS FOR ISOLATING IT AND ITS USE
09/03/1981WO1981002425A1 The use of eucaryotic promoter sequences in the production of proteinaceous materials
09/02/1981EP0034835A1 Cholesterol derivatives as intermediary products for the synthesis of immunologic adjuvants
09/01/1981US4287179 Immersion vaccine for enteric redmouth
09/01/1981US4287178 Feline rhinotracheitis vaccine and production and use thereof
09/01/1981US4287173 Comprising capsular polysaccharides of streptococcus pneumoniae
09/01/1981CA1108051A1 Method for purification of hbs antigen
08/1981
08/26/1981EP0034543A2 Process for solubilization of gonococcal antigen
08/25/1981US4285936 Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa
08/25/1981US4285931 E. coli enterotoxin vaccine for veterinary and human use
08/25/1981US4285930 Antigens comprising immunostimulant adjuvants and their use in immunotherapy
08/25/1981CA1107722A1 2-(2-acetamido2-deoxy-3-o-d-glucopyranosy)-d- propionyl-l-seryl-d-isoglutamine, 2-(2-acetamido-2- deoxy-3-o-d-glucopyranosyl)-d-propionyl-l-seryl-d- glutamic acid, ester and amidederivatives thereof, and medicaments containing them
08/25/1981CA1107648A1 Glycoprotein and process for isolating it
08/18/1981US4284537 Polylysine
08/18/1981CA1107208A1 Stabilized biochemical preparations, preparation and use thereof
08/12/1981EP0033579A2 Hybrid cell line for producing monoclonal antibody to a human monocyte antigen, antibody, and methods
08/12/1981EP0033578A2 Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods
08/11/1981CA1106758A1 Process for the total determination of hormones and pharmaceuticals by enzymatic hydrolysis and use of immobilized antibodies
08/06/1981WO1981002107A1 Highly attenuated varicella virus vaccine and production thereof
08/05/1981EP0033000A1 Protein PP 15, process for its preparation and its use
08/04/1981US4282315 Preparation of enriched whole virus radioligand
08/04/1981US4282210 Method for the control of shipping fever pneumonia in cattle
08/04/1981CA1106360A1 Antigenically active polypeptide and a process for its preparation
08/04/1981CA1106279A1 Hepatitis b core antigen
07/1981
07/28/1981US4280992 Immunologically active substance-glass conjugates, process for producing the same and diagnostic reagents containing the same
07/28/1981CA1105935A1 4-aminomethyl-1-(di-n-alkyloxypropyl)-4- phenylpiperidines as immune stimulants
07/21/1981US4280001 Antibiotic l 13365 produced by actinoplanes
07/21/1981US4279893 Vaccine against Newcastle fowl disease, method for preparing and use thereof
07/21/1981US4279884 Process for preparation of antisera
07/21/1981CA1105383A1 Immunoglobulin having a reduced complement fixation, a process for its preparation and agents containing this immunoglobulin
07/15/1981EP0031999A2 Antitumor protein hybrid and process for the preparation thereof
07/14/1981US4278662 Attenuated influenza type A virus vaccine
07/14/1981US4278651 Supported receptor and use thereof in an assay
07/14/1981CA1105011A1 Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2- deoxyglycosides from glycals
07/14/1981CA1105006A1 Peptides
07/09/1981WO1981001849A1 Purified human prostate antigen
07/08/1981EP0006916B1 Immunological preparations incorporating mhc antigens and their production
06/1981
06/30/1981US4276283 Purification with ammonium sulfate or alkali phosphate, polyethylene glycol, saccharide, water-soluble polymer
06/30/1981CA1104000A1 Particles
06/24/1981EP0030885A2 Microparticles, their preparation and their biological uses, especially in the culture of diploid cells
06/24/1981EP0030815A2 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses, and pharmaceutical compositions comprising this antibody
06/24/1981EP0030814A2 Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
06/24/1981EP0030728A2 Feline leukemia vaccine
06/23/1981US4275165 Process for isolating hepatitis A-virus
06/23/1981US4275000 Peptide macromolecular complexes
06/23/1981US4274417 Instruments for use in the measurement of gases in body fluids